Dynavax Technologies Current Ratio 2006-2021 | DVAX

Dynavax Technologies current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Dynavax Technologies Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.58B $0.21B 2.85
2021-03-31 $0.43B $0.11B 3.91
2020-12-31 $0.29B $0.08B 3.75
2020-09-30 $0.29B $0.07B 4.35
2020-06-30 $0.27B $0.05B 4.99
2020-03-31 $0.19B $0.03B 6.63
2019-12-31 $0.21B $0.05B 3.93
2019-09-30 $0.23B $0.05B 4.94
2019-06-30 $0.19B $0.05B 4.30
2019-03-31 $0.22B $0.04B 5.27
2018-12-31 $0.17B $0.04B 4.59
2018-09-30 $0.20B $0.03B 6.29
2018-06-30 $0.23B $0.03B 8.87
2018-03-31 $0.26B $0.02B 10.85
2017-12-31 $0.20B $0.02B 10.65
2017-09-30 $0.20B $0.01B 15.29
2017-06-30 $0.13B $0.01B 11.92
2017-03-31 $0.09B $0.01B 7.24
2016-12-31 $0.09B $0.02B 4.47
2016-09-30 $0.12B $0.03B 3.86
2016-06-30 $0.15B $0.03B 5.21
2016-03-31 $0.17B $0.03B 6.97
2015-12-31 $0.20B $0.03B 6.95
2015-09-30 $0.22B $0.02B 11.37
2015-06-30 $0.10B $0.02B 4.46
2015-03-31 $0.10B $0.02B 4.98
2014-12-31 $0.13B $0.02B 6.28
2014-09-30 $0.14B $0.02B 5.91
2014-06-30 $0.16B $0.02B 7.96
2014-03-31 $0.18B $0.02B 11.37
2013-12-31 $0.19B $0.02B 11.88
2013-09-30 $0.08B $0.02B 5.13
2013-06-30 $0.09B $0.02B 6.20
2013-03-31 $0.11B $0.02B 6.34
2012-12-31 $0.13B $0.02B 6.74
2012-09-30 $0.15B $0.03B 5.26
2012-06-30 $0.17B $0.03B 6.56
2012-03-31 $0.11B $0.03B 4.27
2011-12-31 $0.13B $0.03B 4.58
2011-09-30 $0.06B $0.01B 5.51
2011-06-30 $0.07B $0.01B 6.29
2011-03-31 $0.06B $0.01B 4.87
2010-12-31 $0.08B $0.01B 5.35
2010-09-30 $0.05B $0.02B 2.39
2010-06-30 $0.06B $0.03B 2.07
2010-03-31 $0.03B $0.02B 2.00
2009-12-31 $0.04B $0.01B 2.64
2009-09-30 $0.05B $0.01B 4.28
2009-06-30 $0.06B $0.01B 4.88
2009-03-31 $0.07B $0.02B 2.70
2008-12-31 $0.08B $0.04B 1.87
2008-09-30 $0.07B $0.02B 3.65
2008-06-30 $0.08B $0.02B 4.99
2008-03-31 $0.09B $0.02B 5.15
2007-12-31 $0.10B $0.02B 5.12
2007-09-30 $0.07B $0.01B 5.32
2007-06-30 $0.09B $0.01B 6.34
2007-03-31 $0.08B $0.01B 6.19
2006-12-31 $0.09B $0.01B 6.55
2006-09-30 $0.06B $0.01B 5.44
2006-06-30 $0.06B $0.01B 7.48
2006-03-31 $0.07B $0.01B 11.18
2005-12-31 $0.08B $0.01B 13.98
2005-09-30 $0.05B $0.01B 8.75
2005-06-30 $0.06B $0.01B 9.90
2005-03-31 $0.07B $0.01B 13.87
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.079B $0.047B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76